ArticleOncology reports2018

Emodin inhibits TGF-β2 by activating the FOXD3/miR‑199a axis in ovarian cancer cells in vitro.

Kejuan Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.